Inexpensive, Luminescent Assay Measures COVID-19 Immunity | AIChE

Inexpensive, Luminescent Assay Measures COVID-19 Immunity

May
2021

At the Univ. of Toronto (U of T), researchers are using a novel technique to measure immunity to COVID-19. With just one pinprick of blood, the assay can detect coronavirus antibodies in under one hour — the quickest and least expensive method yet.

The researchers call their test the serological assay based on split nanoluciferase, or SATiN, for short. It measures immunoglobin G antibodies (IgGs), specifically those that work against SARS-CoV-2. In the presence of coronavirus-specific IgGs, the SATiN mechanism lights up, indicating immunity against COVID-19.

SATiN is based on nanoscale luciferase (NLuc), a luminescent enzyme that detects coronavirus IgGs by splitting into three fragments: β9, β10, and Δ11S. In a blood sample, β9 binds to protein G, a molecule specific to immunoglobin, and β10 binds to the unique spike (S) protein native to SARS-CoV-2. The dual binding of β9 and β10 triggers the Δ11S fragment to luminesce, signifying the presence of coronavirus antibodies.

The scientists tested their...

Would you like to access the complete CEP News Update?

No problem. You just have to complete the following steps.

You have completed 0 of 2 steps.

  1. Log in

    You must be logged in to view this content. Log in now.

  2. AIChE Membership

    You must be an AIChE member to view this article. Join now.

Copyright Permissions 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.